Chris Ritchlin

Suggest Changes
Learn More
OBJECTIVE A list of 14 criteria for guiding the validation of a soluble biomarker as reflecting structural damage endpoints in rheumatoid arthritis (RA) clinical trials was drafted by an(More)
  • 1